ClinicalTrials.gov
ClinicalTrials.gov Menu

Chemoradiation With or Without Nimotuzumab in Treating Esophageal Cancer Patients Who Suffer With Recurrence in Regional Lymph Nodes After Esophagectomy (Nimotuzumab)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01402180
Recruitment Status : Unknown
Verified November 2010 by Fudan University.
Recruitment status was:  Recruiting
First Posted : July 26, 2011
Last Update Posted : July 26, 2011
Sponsor:
Collaborators:
Shanghai Chest Hospital
Shanghai Pulmonary Hospital, Shanghai, China
RenJi Hospital
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Information provided by:
Fudan University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : December 2013
  Estimated Study Completion Date : December 2015